1
views
0
recommends
+1 Recommend
1 collections
0
shares
• Record: found
• Abstract: found
• Article: found
Is Open Access

Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease

Dove

ScienceOpenPublisherPMC
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Background and Objective

Chronic Obstructive Pulmonary Disease (COPD) is a common chronic respiratory disease that in the long term may develop into respiratory failure or even cause death and may coexist with other diseases. Over time, it may incur huge medical expenses, resulting in a heavy socio-economy burden. The BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity) index is a predictor of the number and severity of acute exacerbations of COPD. This study focused on the correlation between the BODE index, comorbidity, and healthcare resource utilization in COPD.

Patients and Methods

This is a retrospective study of clinical outcomes of COPD patients with complete BODE index data in our hospital from January 2015 to December 2016. Based on the patients’ medical records in our hospital’s electronic database from January 1, 2015 to August 31, 2017, we analyzed the correlation between BODE index, Charlson comorbidity index (CCI), and medical resources.

Results

Of the 396 patients with COPD who met the inclusion criteria, 382 (96.5%) were male, with an average age of 71.3 ± 8.4 years. Healthcare resource utilization was positively correlated with the BODE index during the 32 months of retrospective clinical outcomes. The study found a significant association between the BODE index and the CCI of COPD patients ( p < 0.001). In-hospitalization expenses were positively correlated with CCI ( p < 0.001). Under the same CCI, the higher the quartile, the higher the hospitalization expenses. BODE quartiles were positively correlated with number of hospitalizations ( p < 0.001), hospitalization days ( p < 0.001), hospitalization expenses ( p = 0.005), and total medical expenses ( p = 0.024).

Conclusion

This study demonstrates the value of examining the BODE index and comorbidities that can predict healthcare resource utilization in COPD.

Most cited references15

• Record: found

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

(2001)
Bookmark
• Record: found

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

(2004)
Bookmark
• Record: found
• Abstract: found

The economic burden of COPD.

(2000)
COPD is one of the leading causes of morbidity and mortality worldwide and imparts a substantial economic burden on individuals and society. Despite the intense interest in COPD among clinicians and researchers, there is a paucity of data on health-care utilization, costs, and social burden in this population. The total economic costs of COPD morbidity and mortality in the United States were estimated at $23.9 billion in 1993. Direct treatments for COPD-related illness accounted for$14.7 billion, and the remaining \$9.2 billion were indirect morbidity and premature mortality estimated as lost future earnings. Similar data from another US study suggest that 10% of persons with COPD account for > 70% of all medical care costs. International studies of trends in COPD-related hospitalization indicate that although the average length of stay has decreased since 1972, admissions per 1,000 persons per year for COPD have increased in all age groups > 45 years of age. These trends reflect population aging, smoking patterns, institutional factors, and treatment practices.
Bookmark

Author and article information

Journal
Int J Chron Obstruct Pulmon Dis
Int J Chron Obstruct Pulmon Dis
COPD
copd
International Journal of Chronic Obstructive Pulmonary Disease
Dove
1176-9106
1178-2005
19 February 2020
2020
: 15
: 389-395
Affiliations
[1 ]Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital , Kaohsiung City, Taiwan
[2 ]Department of Healthcare Administration and Medical Informatics, Kaohsiung Medical University , Kaohsiung City, Taiwan
[3 ]Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital , Kaohsiung City, Taiwan
[4 ]Chang Gung University College of Medicine , Taoyuan, Taiwan
[5 ]Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital , Kaohsiung City, Taiwan
Author notes
Correspondence: Shih-Feng Liu Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taiwan , No. 123, Ta-Pei Road, Niaosong District, Kaohsiung833, TaiwanTel +886 7 731 7123 ext. 8199Fax +886 7 732 24942 Email liuphysico@yahoo.com.tw
Article
234363
10.2147/COPD.S234363
7036670